Navigation Links
Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
Date:1/24/2008

Portrait because you can heat 100% of the surface and dermis uniformly."

For patients who are not interested in (or good) candidates for surgery, Dr. Biesman recommends Portrait Plasma as a stand alone procedure. "For patients who have moderately droopy, loose, or wrinkled skin, surgery may not be the best option, but Portrait Plasma may be," Dr. Biesman explains. In a study conducted by Dr. Biesman looking at the use of high energy Portrait Plasma skin regeneration compared to blepharoplasty, patients rated their overall improvement with Portrait Plasma as 64%. Dr. Biesman said of his reaction to the initial results, "I am very, very enthusiastic about the changes we are seeing...plasma treatment of the eyelid is a very viable and I think a very exciting technique that can play a nice role in the aesthetic practice." Portrait Plasma now offers patients a number of new treatment options for tightening and significant wrinkle improvement without surgery.

Portrait Plasma harnesses the power of plasma to deliver dramatic skincare results without the risk or down time associated with outdated laser procedures. The hand-piece delivers nitrogen plasma energy that works both at and below the surface of the skin to modify its architecture and generate new collagen for up to two years. Portrait PSR3 has been proven to treat fine lines and deep wrinkles, sun damage and pre-cancerous lesions and dyschromia. It also improves pore size, elasticity, and tone and texture of the face and body.

This in-office procedure takes 20 - 30 minutes for a full face or a targeted body treatment. Localized procedures around the eyes and mouth can be done in as little as 10 to 15 minutes. There is no additional downtime when blepharoplasty and/or injectables and fillers are used in conjunction with Portrait Plasma.

About Rhytec - The Makers of Portrait Plasma:

Rhytec develops innovative plasma technologies based on sound scientific and clinical research for th
'/>"/>

SOURCE Rhytec, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
2. GSK Does Not Option XL784 for Further Development
3. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
4. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
7. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
8. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
9. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
10. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
11. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2008)...LIN, Mass., Nov. 26 PLC ... today that it has received full approval from the....S. pivotal trial to study the effectiveness of th...therapy in the prevention of Contrast-Induced Neph...C,s request to expand their investigation from the...
(Date:11/25/2008)...e-FirstCall/ -- Poniard,Pharmaceuticals, Inc. (Na...d on,innovative oncology therapies, announced tod...es for its preclinical research programs in order ...e clinical development of picoplatin,its lead pr...cialization of,picoplatin in the treatment of sma...
(Date:11/24/2008)...o,s Pizza (NYSE: DPZ ), the,recognized world le...gh for,the kids of St. Jude Children,s Research H... campaign. Domino,s customers will have the opport...benefit the children of St. Jude.,Donations can b...ng online at, www.dominos.com . The campaign begi...
(Date:11/24/2008).../ -- Schering-Plough Corporation (NYSE: SGP ) to...tive adenosine2a receptor antagonist, met the prim...atients suffering from moderate to severe Parkinso...normal involuntary movements (dyskinesias). The t... 2008 R&D Update meeting being hosted for anal...
Breaking Medicine Technology:PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 2Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 3Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 4Penn Research Shows Transcranial Magnetic Stimulation Effective in Treating Major Depression 913 1Penn Research Shows Transcranial Magnetic Stimulation Effective in Treating Major Depression 913 2Penn Research Shows Transcranial Magnetic Stimulation Effective in Treating Major Depression 913 3ATV Injuries on the Rise 6905 1ATV Injuries on the Rise 6905 2ATV Injuries on the Rise 6905 3Environmental exodus 1331 1Environmental exodus 1331 2Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers Newark Provost Award 6903 1Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers Newark Provost Award 6903 2
...sults Presented At ASCO -- , CHICAGO – June ... interferon alfa-2b in stage III melanoma had a,si...vival (RFS),according to the results of the large...stage III melanoma. Results of the Phase,III study...h and,Treatment of Cancer (EORTC) and supported by...
...007 - MGI Pharma, Inc.,(Nasdaq:MOGN), a biopharmac..., today provided highlights of data presentations ...Oncology (ASCO) Annual,Meeting. Dacogen (decitabin...ncluding the presentation of efficacy data in olde...nd activity,observed in patients with refractory a...
Other Medicine Technology:Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 2Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 4Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10
(Date:12/1/2008)... are developing a wide variety of arm, wrist and h...ly described gymnastic-related trauma, according t... the Radiological Society of North America (RSNA)....s unusual and might point to something new going o...thletes in different ways," said the study,s lead ...
(Date:12/1/2008)...n the Dec. 1 issue of the journal Sleep is the f...exposure strongly modify sleep patterns in preterm...or developmental difficulties that could persist t... indicate that preterm neonates born to heavy-smok... day displayed disrupted sleep structure and sleep...
(Date:11/30/2008)...Newswire/ -- Combining an ultrasound-guided techni... at relieving the common and painful foot problem ...sented today at the annual meeting of the Radiolog..."There is no widely accepted therapy or standard o...l to relieve the pain of plantar fasciitis," said ...
(Date:11/30/2008)... 1 Faint magnetic,sign...ow that those children,process sound and language...ng,and classifying these brain response patterns ... autism and possibly aid in developing more effect... Timing appears to be crucial. "Children wit...
Breaking Medicine News(10 mins):Health News:MRI shows new types of injuries in young gymnasts 2Health News:High levels of prenatal smoking exposure affect sleep patterns in preterm neonates 2Health News:High levels of prenatal smoking exposure affect sleep patterns in preterm neonates 3Health News:New Treatment Eliminates Heel Pain Caused by Plantar Fasciitis 2Health News:New Treatment Eliminates Heel Pain Caused by Plantar Fasciitis 3Health News:Brain's Magnetic Fields Reveal Language Delays in Autism 2Health News:Brain's Magnetic Fields Reveal Language Delays in Autism 3
...neers have announced that they have created a comp...he topical microbicides// used by women for preven...cides are needed since the infections globally are... physics and chemistry, the researchers developed ...
...ren's Research Hospital have discovered that a pro...on of a molecule that is key to the ability// of r...break down toxins, and of cells to extract energy ...ators showed that ABCB6 is lodged within the outer...
...hat twins are performing on par with other childre...y the performance of the twins// has been found wa...e students. Researchers felt this was because twin...as well as have low educational motivation. The D...
...ates among younger and older Americans have been d...news: No one really knows why// . Those are the f... University of South Carolina and released Thursda... issue of the American Journal of Public Health. ...
Other Medicine News:Health News:Computer Tool Predicts Effectiveness Of Microbicides 2Health News:Computer Tool Predicts Effectiveness Of Microbicides 3Health News:ABCB6 Is Key to Production of Heme in Hemoglobin 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 3
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: